<DOC>
	<DOCNO>NCT00172341</DOCNO>
	<brief_summary>Asthma , airway inflammatory disorder , important chronic disease child . About 10~15 % child bother . Allergens , house-dust mite ( HDM ) , animal dander ( i.e . cat dog ) , seasonal pollen , often implicated causative trigger factor respiratory attack child asthma . Among , mite common indoor allergen associate asthma worldwide . It appear SLIT somewhat effective safe . However , current evidence , study need define indication , duration treatment therapeutic optimal dose standardize allergen extract relation efficacy side effect recommend routine clinical use . The objective present study investigate effect safety StaloralTM , standardize extract D. pt . D. f. , asthmatic child allergic HDM .</brief_summary>
	<brief_title>Sublingual Immunotherapy With House Dust Mite Extract Asthmatic Children</brief_title>
	<detailed_description />
	<criteria>Patients age 5 15 year ; either sex· Patients asthma least one year clinical history sensitization domestic mite , skin ( prick test ) test positive D. pt . D. f. show wheal ³ 5mm , specific D. pt . IgE rate ³ Class 4+ test CAP System· Patients least 1year history mild moderate severity asthma [ Steps 2 3 GINA ( global initiative asthma ) ] A ) Mild persistent asthma ( Step 2 GINA ) , characterize Symptoms : &gt; 2 time per week &lt; 1 time per day Exacerbations : Affect activity sleep Nighttime asthma symptom : &gt; 2 time per month PEF ( peak expiratory flow ) FEV1 ( forced expiratory volume first second ) ³ 80 % predict variability 2030 % B ) Moderate persistent asthma ( Step 3 GINA ) , characterize Symptoms : Daily Exacerbations : Affect activity sleep Nighttime asthma symptom : &gt; 1 time per week PEF FEV1 60 &lt; &lt; 80 % predicted variability &gt; 30 % Reversibility PEFR ( peak expiratory flow rate ) ³ 15 % inhaled b2agonists· Patients parent give informed consent· Patients FEV1 great 70 % predicted· Patients without hypersensitivity airborne allergen standardize prick test panel except house dust mites Perennial allergenic asthma cosensitization Cockroach , Alternaria Cladosporium , dog and/or cat dander seasonal asthma due pollen . The cosensitization involve establish : Pertinent clinical history Positive skin prick test ( wheal ³5mm ) Specific IgE rate ³2+ ( test CAP ) · Patients treat subcutaneous immunotherapy D. pt . D. f. mite past 2 years· Patients contraindication specificallergen immunotherapy , immunodepression , autoimmune disease , progressive nephropathy malignancy system· Patients peptic ulcer , refluxesophagitis condition ulcer/erosion prove upper gastroenteric endoscopy history upper gastroenteric tract bleeding· Patients anatomical abnormality upper respiratory tracts· Patients atopic dermatitis · Patients participate clinical trial within past 3 month prior study· Patients form administration immunotherapy previous year ongoing· Patients history cardiovascular , psychotic medical immunologic diseases· Patients active pulmonary disease tuberculosis , pneumonia pulmonary edema· Patients treat oral parenteral corticosteroid ( 15 consecutive day ) , depot steroid , inhaled corticosteroid dosage great 1000 mg/day ( beclomethasone dipropionate ) , inhaled b2agonists four time daily and/or oral b2agonists methylxanthines· Female patient pregnant , nurse childbearing potential include .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>July 2004</verification_date>
</DOC>